Ardent Health Partners Inc
ARDT
ISIN null / Valor 136301364
Ardent Health Partners Inc
UMushroom community rating:
About company
Ardent Health Partners Inc, established in 2001, is a prominent healthcare provider in the United States, operating a network that includes 30 hospitals and over 200 care sites across six states. The company employs more than 24,000 team members and collaborates with over 1,700 healthcare providers, collectively serving over 15,000 patients daily. Ardent Health Partners focuses on delivering comprehensive healthcare services, aiming to enhance patient outcomes and foster healthier communities through its extensive network of facilities and dedicated healthcare professionals.
Summarized from source with an LLMView SourceSector: HealthcareLatest Results (08.10.2025):
Ardent Health Partners Inc. reported strong financial results for the third quarter of 2024, showing significant growth in revenue, net income, and adjusted EBITDA compared to the same period last year. The company's strategic initiatives and operational efficiencies have positioned it well for continued growth, leading to an upward revision of its full-year guidance.
Revenue Growth
Total revenue for Q3 2024 increased by 5.2% year-over-year to $1.45 billion, driven by a 3.8% rise in adjusted admissions and a 0.9% growth in net patient service revenue per adjusted admission.
Net Income Improvement
Net income attributable to Ardent Health reached $26 million, or $0.19 per share, up from $21 million, or $0.17 per share, in Q3 2023.
Adjusted EBITDA Surge
Adjusted EBITDA grew by 15.3% year-over-year to $98 million, with margin expansion of 50 basis points to 6.7%, reflecting higher patient volumes and effective cost management.
Admissions and Service Revenue
Adjusted admissions increased by 3.8% year-over-year, while net patient service revenue per adjusted admission grew by 0.9%, contributing to overall revenue growth.
Strategic Initiatives
The company's focus on service line optimization, supply chain efficiency, and the deployment of AI technologies has enhanced operational performance and clinical outcomes.
Updated Financial Guidance
Ardent Health has raised its full-year 2024 adjusted EBITDA guidance midpoint by 2% and modestly improved its revenue outlook, reflecting confidence in ongoing strategic execution and strong third-quarter performance.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
1245 M
Market cap (USD)
1,105,808
Daily traded volume (Shares)
16.91 / 16.5
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
